Loading organizations...
Loading organizations...
Hillsborough Venture functions as a seed venture capital firm, primarily focused on early-stage investments across various technology and life science sectors. The firm deploys capital into nascent enterprises, often participating in critical early funding rounds to facilitate the development and growth of innovative solutions. Its investment approach emphasizes identifying high-potential startups and providing foundational financial support.
The firm is notably associated with Bobby Lent, a respected figure within the Silicon Valley investment community. Lent established the venture, sometimes known as Hillsven, with an insight into the necessity of early-stage strategic capital to transform promising concepts into viable businesses. His significant experience informed the firm’s investment philosophy.
Hillsborough Venture historically supported entrepreneurial teams and groundbreaking companies seeking initial financial backing to scale their operations. The firm's overarching vision centered on empowering founders and contributing to the advancement of cutting-edge technologies and therapeutic developments, guiding portfolio companies through formative stages for long-term impact.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2020 | Tranquis Therapeutics | $30.0M Series A | Remiges Ventures, SR One | Vivo Capital, Correlation Ventures |